FDA Approval and Access Strategy for Lenacapavi...

By Rene Pretorius

June 20, 2025

Summary The FDA has approved Yeztugo (lenacapavir), a revolutionary twice-yearly injection that redefines ...
Quantifying EU Medicine Access Challenges
South Africa Health Reform: A Critical Examination of Universal Coverage Prop...
Another GLP-1 Drug Access Model: Will a Co-Pay Cap Revolutionize Affordability?
Biosimilars Price Competition: Impact on U.S. Pharmaceutical Pricing and Mark...
Drug Pricing Analysis: ICER’s Launch Price and Access Report Aims to En...
Trends in Anticancer Drug Pricing: Analyzing Medicare Launch Prices and Impac...
Prevention Valuation: Fund Health, Not Just Savings
Wegovy CVS Deal: Hybrid Market Access Strategy Insights
Journavx for Pain Management: Toward Affordability and Access
Reassuring the Private Sector on National Health Insurance South Africa: A Pa...
A Shared-Value Model for Enhancing Diabetes Care in South Africa
Prior Authorization Elimination: Is Optum Rx moving towards Access Efficiency?